Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases

The UK's largest pharmaceutical company, Rafa, has announced a joint partnership with the British Pharmaceuticals and Drug Administration (FDA) to promote access to medicines for rare diseases in developing countries in the Middle East and Eastern Europe (CEE).

Source: prnewswire.com
Published on 2022-08-02